As autumn arrives in Europe, the global diabetes community turns its attention to Milan, Italy—the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) will be held from September 28 to October 2 at the Allianz MiCo – Milan Convention Centre. This prestigious event is expected to attract over 14,000 delegates from more than 130 countries, serving as a pivotal platform for showcasing breakthroughs in diabetes research, treatment, and care while addressing the growing challenges of this global epidemic. We sincerely invite you to visit Sejoy Booth F.02 to explore the forefront of the industry together.
Europe is at the cutting edge of diabetes innovation, with over 60 million people living with diabetes in the region, making it one of the most advanced healthcare markets in the world. The European market leads in the adoption of cutting-edge technologies such as continuous glucose monitoring (CGM) and advanced insulin delivery systems, with a projected compound annual growth rate of 7.2% through 2030. This year’s conference comes at a critical moment when the prevalence of diabetes in Europe, especially among young people, is on the rise, driving demand for more effective, patient-centric solutions.
The scientific program of EASD 2026 covers over 1,400 abstracts, involving all aspects of diabetes care, from groundbreaking basic research to transformative clinical applications. Attendees will delve into emerging trends such as once-weekly insulin formulations, next-generation GLP-1 therapies with multi-organ benefits, and AI-driven personalized treatment algorithms. The conference will also focus on the latest advances in diabetes prevention, including early intervention strategies and lifestyle modifications that can delay or even reverse the progression of type 2 diabetes.
In addition to scientific sessions, the exhibition hall will become a hub for innovation, bringing together leading pharmaceutical companies, medical device manufacturers, and digital health startups. This year’s event will showcase the strength of the European market in medical technology, with local and international companies presenting state-of-the-art solutions that combine clinical excellence with user-centric design. From smart insulin pens that automatically log doses to AI-powered platforms that predict hypoglycemic events, the exhibition area will demonstrate how technology is transforming diabetes management.
Milan, a city renowned for its blend of history and innovation, provides the perfect backdrop for this gathering of global experts. As a major hub for medical research and healthcare innovation in Europe, Milan offers attendees access to top academic institutions, cutting-edge research facilities, and a vibrant healthcare ecosystem. The city’s central location also makes it an ideal meeting point for professionals across Europe and beyond, fostering collaboration that transcends national boundaries.
For healthcare providers, researchers, and industry professionals, EASD 2026 is more than just a conference—it is an opportunity to shape the future of diabetes care. With the European market leading in regulatory innovation and patient access to advanced therapies, the insights gained in Milan will have far-reaching implications for global diabetes management. As we gather to share knowledge, discuss emerging trends, and celebrate scientific achievements, we are moving closer to a world where diabetes no longer represents a life-limiting condition.
Welcome to this historic city, and let us work together to advance diabetes care through innovation, collaboration, and a shared commitment to improving lives. The future of diabetes management starts here—in Milan, at EASD 2026, and at Sejoy Booth F.02. We look forward to meeting you and co-creating a new blueprint for the industry.
Post time: Sep-26-2026